共查询到18条相似文献,搜索用时 125 毫秒
1.
目的 研究类风湿性关节炎(RA)患者不同时期外周血Treg和Th1、Th2、Th17细胞以及中性粒细胞上CD64的表达水平,及它们与RA的活动性指标和自身抗体的相关性.方法 采集78例RA患者和21例健康人外周静脉血,采用流式细胞术检测淋巴细胞亚群(Treg,Th1、Th2、Th17细胞)的变化.结果 RA的CD3+ CD4+T细胞和CD4+ CD25+T细胞增多,活动期RA组Treg比率高于缓解期RA组和健康对照组,缓解期RA组Th2细胞减少,RA中Th1,TH17细胞与健康对照组相比无统计学意义,Treg和Th1、Th2、Th17细胞与RA的活动性指标(ESR,CRP和PLT)均无关联.结论 CD4+T细胞亚群数量异常可能与RA疾病发展有关. 相似文献
2.
目的:研究RF因子阳性及阴性RA患者之间是否存在基因组学的差异,探询差异存在的基因表达基础.方法:应用基因表达谱方法来检测上述两型患者CD4 淋巴细胞基因表达情况.结果:RF因子阳性与阴性患者之间有55条基因表达差异有统计学意义.结论:RF因子阳性与阴性RA患者之间存在差异表达基因,这些差异基因多与免疫应答相关. 相似文献
3.
类风湿关节炎 (RheumatoidArthritis ,RA)是一种累及全身多关节的自身免疫性炎症性疾病 ,其病理特征之一为炎性滑膜浸润大量CD4 + T细胞 ,滑膜细胞增生及血管翳形成 ,其机理仍未阐明。有学者认为RA的发病与细胞凋亡过程异常有关 ,并有多种细胞参与 ,包括滑膜细胞、成纤维细胞、淋巴细胞、软骨细胞等[1] 。本实验应用末端脱氧核苷酸转移酶介导的缺口末端标记法 (TUNEL)和流式细胞术 ,探讨细胞凋亡在RA发病机制中的作用。1 材料与方法1 1 标本 RA患者滑膜组织和外周血取自 8例RA病人 ,RA诊断根据 1987年美国风湿病学会(ACR)修订… 相似文献
4.
目的:研究CD4 CD25 FoxP3 调节性T细胞在类风湿关节炎患者(RA)外周血中的比例改变,并探讨其在疾病进程中的意义.方法:选取活动期及稳定期RA患者,采用细胞内染色的流式细胞术及定量PCR的方法,分别在蛋白质和mRNA水平检测FoxP3表达,并与正常人进行比较.结果:RA患者CD4和CD25双阳性细胞所占比例与对照组没有明显差异,而活动期患者外周血CD4 CD25high和CD4 CD25 FoxP3 细胞明显低于稳定期和对照组(P<0.05).FoxP3 mRNA表达水平与蛋白质表达水平变化相一致.结论:类风湿性关节炎活动期时CD4 CD25 FoxP3 调节性T细胞明显减少,这群调节性T细胞可能参与了类风湿性关节炎的病理进程. 相似文献
5.
目的观察类风湿性关节炎(RA)活动期外周血CT4+T淋巴细胞的表型变化,探讨其免疫病理机制。方法采用ELISA和双标记免疫荧光法检测50例活动期RA患者和50例健康成人外周血CD4+T细胞表面CD154、CD69的表达以及血清、血浆可溶性CD154(sCD154)的含量。结果活动期RA患者的外周血CD4+T细胞CD154(16.8%±7.9%)和CD69(14.1%±8.2%)的表达水平均显著高于健康人,其血清sCD154(18.56±6.32,ng/ml)和血浆sCD154(8.41±3.51,ng/ml)含量亦分别高于健康人血清sCD154(9.56±4.71,ng/ml)和血浆sCD154(2.98±1.13,ng/ml)。结论CD4+T细胞表达的CD154、CD69以及血浆sCD154含量与RA的活动相关,可以作为RA的辅助诊断、疗效评价和预后判断的有价值的实验室参数。 相似文献
6.
了解具有抑制功能的CD4+CD25+调节性T细胞(Treg)在类风湿关节炎(RA)中的水平变化。分离32例RA患者及35例正常对照者外周血和15例RA关节滑液中的单个核细胞,用荧光抗体标记细胞膜表面CD4、CD25分子和细胞内Foxp3转录因子,进行流式细胞分析,同时用RT-PCR方法测定单个核细胞中Foxp3 mRNA水平。实验发现RA外周血中CD4+CD25hT细胞比例(1.90±1.68)与健康人(1.81±1.79)无明显差异,而RA关节滑液中CD4+CD25+和CD4+CD25hT细胞含量却明显增高(14.98±12.52,8.94±9.67,P<0.01)。RA患者外周血单个核细胞中Foxp3+/CD4+T细胞比值(2.35±2.06)较正常人(7.25±3.98)明显降低(P<0.01),RA外周血中Foxp3 mRNA含量较正常人Treg减少,而RA关节液中Foxp3 mRNA含量较RA外周血更为低下(P<0.01)。RA患者存在CD4+CD25+Treg的异常改变,其外周血和关节液中具有抑制作用的Treg含量明显降低提示RA患者Treg数量减少及抑制功能下降可能是RA自身免疫反应亢强不能控制的原因之一。RA关节液中CD4+CD25hT细胞增高考虑与RA炎症反应造成T细胞过度活化有关。 相似文献
7.
类风湿性关节炎(RA)是一种病因尚未明确的慢性、全身炎症性自身免疫性疾病,发病机制非常复杂,遗传、环境和免疫因素可能共同发挥作用。免疫功能失衡尤其是CD4+T细胞中的辅助T细胞亚群Th1、Th2、Th17细胞、调节性T细胞(Treg)免疫功能失衡被认为是诱导RA发病的中心环节,进而导致关节滑膜细胞增生、血管翳的形成、炎性细胞浸润并伴有不同程度的软骨及骨质的侵蚀。因此,及时矫正Th1/Th2、Th17/Treg比例、功能及相关因子网络的免疫紊乱,可能是RA治疗新的有效靶点。虽然目前越来越多的研究证明Treg、Th1、Th2、Th17细胞参与RA各个发展进程,但报道的结果却不尽相同,现就目前发现的与RA相关的CD4+T细胞亚群的研究进行综述。 相似文献
8.
目的:分析SLE和RA患者外周血CD4+CD25highTreg和CD4+CD25low T细胞的数量变化以及两群细胞表面协同刺激分子PD-1分子的表达情况,初步探讨PD-1表达异常在SLE和RA患者细胞免疫失调中的意义.方法:流式细胞术(FCM)检测CD4+CD25highTreg和CD4+CD25lowT细胞的比率以及PD-1的表达率.结果:与健康对照组相比,SLE和RA患者组外周血CD4+CD25highTreg的比率均明显降低(P<0.05);两疾病组间相比,SLE组CD4+CD25highTreg的比率更低(P<0.05).RA患者组CD4+CD25highTreg表面PD-1的表达率明显低于健康对照和SLE组(P<0.05),而SLE组该指标与健康对照无统计学差异(P>0.05).CD4+CD25lowT细胞以及该群细胞上PD-1的表达率在三组间无统计学差异.结论:外周血CD4+CD25highTreg生成不足导致其对效应性T细胞的抑制能力减弱是SLE和RA患者的共同特征;PD-1表达降低可能是RA患者CD4+CD25high曲Treg免疫调节紊乱的重要机制,而在SLE患者PD-1分子并不是影响免疫稳态的主要因素. 相似文献
9.
CD4~+CD25~+调节性T细胞(Treg)在维持机体自身耐受和预防自身免疫性疾病方面发挥重要作用,其功能失调在类风湿关节炎(rheumatoid arthritis,RA)发病中同样起重要作用。因此,对CD4~+CD25~+Treg在RA中的深入研究不仅能进一步了解RA的发病机制,也为治疗RA提供了新的途径。 相似文献
11.
Gene expression profiling using microarray technology is being employed to define specific molecular mediators and pathways involved in immunobiology, to understand the intricate interplay of genes participating in the pathogenesis, and to develop biomarkers of disease activity in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This review summarizes the latest information on the pathogenesis of SLE and RA and describes the utilization of microarray technology in these systemic autoimmune diseases. 相似文献
13.
Rheumatoid arthritis (RA) is characterized by a chronic inflammatory process that targets the synovial lining of diarthrodial joints. TIM‐3 plays a key role in the negative regulation of the immune response. In this study, we investigated the expression of TIM‐3 on CD4+ and CD8+ T cells from systemic (peripheral blood) and local (synovial fluid) perspectives of RA. Level of TIM‐3+ cells from peripheral blood and synovial fluid of patients as well as peripheral blood of healthy controls was measured by flow cytometry. Results showed that TIM‐3 expression was significantly increased in both CD4+ and CD8+ T cells in the peripheral blood of RA (p < 0.001 and p < 0.001, respectively). Furthermore, patients revealed even higher expression of TIM‐3 in CD4+ and CD8+ T cells in synovial fluid than in peripheral blood. When comparing TIM‐3 level with the severity of RA, we identified that the percentage of TIM‐3 on both peripheral CD4+ and peripheral CD8+ T cells was negatively correlated with disease activity score 28 (DAS28) of the patients. Similarly, TIM‐3 on synovial fluid CD4+ and CD8+ T cells also revealed inverse correlation with DAS28 of the cases. Our data demonstrate a negative correlation between TIM‐3 and the disease progression of RA. 相似文献
14.
目的研究类风湿性关节炎(RA)患者病情发展不同阶段外周血及滑液中CD4 CD25high调节性T细胞数量的差别,及其与类风湿性关节炎活动程度的相关性,探讨CD4 CD25highT细胞在RA发生发展中所发挥的免疫抑制和调节作用。方法分别选取未经过缓解病情抗风湿药(DMARDs)治疗的活动性RA患者11例,经DMARDs治疗病情缓解的RA患者12例,和DMARDs治疗后效果不佳的RA患者9例,以及正常对照8例,检测他们的外周血淋巴细胞,以流式细胞术检测CD4 CD25high调节性T细胞的百分率,并研究CD4 CD25highT细胞百分率与抗环瓜氨酸(CCP)抗体,C反应蛋白(CRP),血沉(ESR)及类风湿因子(RF)的相关性。对其中部分患者的血液和关节滑液同时进行分析。结果RA未经治疗组和治疗效果不佳组CD4 CD25highT细胞的百分率(分别是5.24%和6.43%)明显低于正常对照组和治疗后病情缓解组(分别是17.17%和11.79%,P<0.01)。RA患者CD4 CD25highT细胞的百分率与抗CCP抗体(58.0Ru/mL),ESR(38.8mm/h)及CRP(2.73μg/L)呈明显负相关(P<0.05),与类风湿因子(RF=14.4Iu/mL)无明显的相关性(P=0.054)。正常对照组的CD4 CD25highT细胞百分率与抗CCP抗体(均<5.0Ru/mL),ESR(4.67mm/h),CRP(0.15μg/L)及RF(1.37)无明显相关性(P>0.1)。RA患者关节滑液中CD4 CD25highT百分率明显低于强直性脊柱炎(ankilosing spondylitis,AS)关节积液患者(P<0.05)。结论试验结果表明未经缓解病情治疗和治疗后效果不佳者的外周血中,CD4 CD25high调节性T细胞相对减少,且与病情活动程度负相关,这可能是RA发生和发展的一个重要因素。 相似文献
15.
Production of CCR5 expression and MIP-1alpha, a ligand of CCR5, by CD4+ T cells from patients with rheumatoid arthritis (RA) were studied. We analysed further the influence of IL-15 stimulation, CD40/CD40 ligand (CD40L) interaction and CCR5 promotor polymorphism. One hundred and fifty-five RA patients and another 155 age- and sex-matched healthy individuals were enrolled. Peripheral CD4+ and double negative (DN) T cells from patients had lower portions of CCR5, whereas synovial CD4+ and DN T cells showed a much higher CCR5 expression. IL-15 significantly up-regulated the expression of CCR5 on purified CD4+ T cells. CD40L expression on synovial CD4+ T cells was increased greatly in CCR5+ portions by IL-15. MIP-1alpha production by synovial CD4+ T cells was also enhanced by IL-15. Co-culture of CD40 expressing synovial fibroblasts with IL-15-activated synovial CD4+ T cells significantly increased MIP-1alpha production. Expression of CCR5 on patients' CD4+ T cells was not influenced by the promotor polymorphism of CCR5 gene. Taken together, these data suggest CCR5+CD4+ T cells infiltrate the inflamed synovium and IL-15 up-regulates CCR5 and CD40L expression further and enhance MIP-1alpha production in synovial CD4+ T cells. Production of MIP-1alpha by synovial fibroblasts is significantly increased by engagement of CD40 with CD40L. Synovial microenvironment plays a potential role in regulation of CCR5+CD4+ T cells in rheumatoid joints. 相似文献
16.
Our aim was to elucidate the relative amount of the different splice forms of FoxP3 mRNA in CD4+ T cells in peripheral blood (PB) compared to synovial fluid (SF) in RA and PsA patients. FoxP3 mRNA was measured using a quantitative real-time PCR method. CD4+ T cells were isolated from 17 paired samples of PB and SF from RA and PsA patients, and PB from 10 controls. FoxP3fl and FoxP3Δ2 mRNA was significantly increased (6.7 and 2.1-fold, respectively) in PB CD4+ T cells from RA patients compared to controls. FoxP3fl and Δ2 mRNA in SF CD4+ T cells was increased compared to controls in sero-negative RA and PsA, but not in sero-positive RA patients, who had a high FoxP3 expression in both PB and SF. The FoxP3Δ2Δ7 mRNA was barely detectable in patient samples, and not at all in healthy individuals. We provide evidence of an increased expression of FoxP3 splice forms in synovial CD4+ T cells from RA patients. A skewed, high expression profile of FoxP3, but not CTLA-4, in sero-negative RA and PsA, indicates that synovial CD4+ T cells may represent unique subsets of T cells which have been induced locally or selectively recruited to the joint. 相似文献
17.
We have investigated whether T cell activation in rheumatoid arthritis (RA) preferentially engages distinct T cell subpopulations in the peripheral blood (PB) and in the synovial fluid. We found that CD25 expression was enhanced among PB CD4 T cells of RA patients as compared with CD4 cells of patients with reactive arthritis, degenerative joint disease or of healthy controls. Within the CD4 T lymphocytes subset we found that the CD45RO- (naive) cells selectively in RA displayed higher levels of CD25 protein and of interferon-gamma mRNA expression when compared with the respective subset of all other investigated groups. These results show that in the PB of RA, but not in the PB of the other arthropathies or healthy controls, CD45RO-CD4 T lymphocytes exist which display well-defined signs of activation. 相似文献
18.
Objectives: Recent evidence has demonstrated that UBASH3A play a pivotal role in multiple autoimmune diseases. In this study, we explored the association between UBASH3A gene single-nucleotide polymorphisms (SNPs) and rheumatoid arthritis (RA) in a Chinese Han population. We also comparatively evaluated the UBASH3A expression profile in peripheral blood mononuclear cells (PBMCs) from patients with RA and healthy controls. Methods: Four UBASH3A polymorphisms (rs1893592, rs11203203, rs2277798, and rs3788013) were studied in 553 patients with RA and 587 controls in a Chinese population. Genotyping was performed using the Fluidigm 192.24 Dynamic Array Integrated Fluidic Circuit (IFC). For gene expression study, UBASH3A mRNA levels of 30 RA patients and 31 healthy individuals were assessed by real-time quantitative polymerase chain reaction (RT-qPCR). Data were analyzed by SPSS 19.0 software. Results: A significant association between rs1893592 polymorphism and RA was found under all genetic models (all p<.05). We also discovered a significant association between rs3788013 polymorphism and RA in the allele and genotype distributions, as well as the recessive model (all p<.05). Moreover, we found the genotype distribution and allele frequency of rs1893592 were significantly associated with RF phenotype in the RA patients (χ2?=?6.786, p=.034; χ2?=?4.534, p=.033; respectively). We also found the genotype distribution and allele frequency of rs2277798 were significantly associated with anti-CCP phenotype in the RA patients (χ2?=?7.873, p=.020; χ2?=?4.473, p=.034; respectively). However, we did not detect any significant associations between rs11203203 and RA susceptibility and autoantibody profiles (all p>.05). The mRNA expression of UBASH3A was increased in PBMCs of patients with RA when compared to healthy controls (p=.001). Conclusions: Our observations suggested that the dysregulation of UBASH3A might be associated with the pathogenesis of RA, and UBASH3A gene polymorphisms (rs1893592 and rs3788013) might contribute to RA susceptibility in Chinese Han population. 相似文献
|